Arcturus Therapeutics (ARCT) - Bathi resik saben saham (EPS TTM)

Arcturus Therapeutics (ARCT) is based on mRNA delivery patents, creating a foundation for monetization. The company adheres to trial ethics and biosafety standards within the ESG framework. Royalties from COVID-19 vaccine sales are driving current growth. This chart illustrates the rolling annual income per share calculated by the GURU.Markets system, where the -3.06 indicator determines the parameter status.

ARCT (arcturusrx.com) riwayat Bathi saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 15.11.2026

Rincian metrik komprehensif lan analitis Arcturus Pharma (ARCT)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Arcturus Therapeutics|ARCT - Bagan tingkat prakiraan

- indikator kapitalisasi pasar:

Kapitalisasi pasar Arcturus Therapeutics Holdings Inc.|ARCT - Total Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Arcturus Therapeutics|ARCT - Kapitalisasi Akuntansi|Rasio Kapitalisasi marang Aset Bersih arcturusrx.com|ARCT - Nilai Agregat Aset

- rincian utang lan likuiditas:

Utang marang Ekuitas Arcturus Therapeutics|ARCT - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Arcturus Therapeutics|ARCT - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Arcturus Therapeutics Inc|ARCT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Arcturus Therapeutics|Likuiditas cepet arcturusrx.com

- indikator pendapatan resik lan kelipatan nilai:

ARCT - Penghasilan resik|Proyeksi bathi mangsa ngarep Arcturus Therapeutics|ARCT - Pangali P/E|Pangali Forward P/E Arcturus Therapeutics Inc|ARCT - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Arcturus Corp|ARCT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Arcturus Therapeutics|ARCT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan arcturusrx.com|ARCT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcturus Therapeutics

- informasi babagan volume dodolan lan pendapatan:

ARCT - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Arcturus Therapeutics Holdings Inc.|ARCT - Rasio kapitalisasi pasar marang pendapatan|Multiplikator forward rega marang pendapatan Arcturus Therapeutics Inc|ARCT - Wutah dodolan YoY (TTM)

Analisis umum perusahaan:arcturusrx.com (ARCT)

Amidst a fierce battle for RNA patents against biotech giants, the financial stability of Arcturus Therapeutics (ARCT) depends directly on its ability to generate real revenue. By analyzing the trailing twelve-month earnings per share, an investor assesses the net operating result stripped of dilution pressure, which allows for the identification of capital freeze risks through the dynamics of earnings per share.

Pesaing Arcturus Therapeutics (ARCT)